Windsor JA - Search Results

1

Is Margin Status Less Prognostic After Neoadjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma?

Windsor JA, Callery MP. Windsor JA, et al. Ann Surg Oncol. 2022 Jan;29(1):20-22. doi: 10.1245/s10434-021-10885-3. Epub 2021 Oct 15. Ann Surg Oncol. 2022. PMID: 34654987 No abstract available.

2

Meta-analysis and cost effective analysis of portal-superior mesenteric vein resection during pancreatoduodenectomy: Impact on margin status and survival.

Bell R, Ao BT, Ironside N, Bartlett A, Windsor JA, Pandanaboyana S. Bell R, et al. Among authors: windsor ja. Surg Oncol. 2017 Mar;26(1):53-62. doi: 10.1016/j.suronc.2016.12.007. Epub 2017 Jan 10. Surg Oncol. 2017. PMID: 28317585 Review.

3

Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index.

Yang F, Wu W, Wang X, Zhang Q, Bao Y, Zhou Z, Jin C, Ji Y, Windsor JA, Lou W, Fu D. Yang F, et al. Among authors: windsor ja. Ann Surg Oncol. 2021 Jan;28(1):550-559. doi: 10.1245/s10434-020-08626-z. Epub 2020 May 18. Ann Surg Oncol. 2021. PMID: 32424583

4

Borderline Resectable Pancreatic Cancer: Answering the Most Important Question First.

Windsor JA. Windsor JA. JAMA Surg. 2016 Aug 17;151(8):e161150. doi: 10.1001/jamasurg.2016.1150. Epub 2016 Aug 17. JAMA Surg. 2016. PMID: 27276510 No abstract available.

5

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL. Isaji S, et al. Among authors: windsor ja. Pancreatology. 2018 Jan;18(1):2-11. doi: 10.1016/j.pan.2017.11.011. Epub 2017 Nov 22. Pancreatology. 2018. PMID: 29191513 Free article.

6

Fluid therapy in acute pancreatitis: anybody's guess.

Haydock MD, Mittal A, Wilms HR, Phillips A, Petrov MS, Windsor JA. Haydock MD, et al. Among authors: windsor ja. Ann Surg. 2013 Feb;257(2):182-8. doi: 10.1097/SLA.0b013e31827773ff. Ann Surg. 2013. PMID: 23207241 Review.

7

Justifying vein resection with pancreatoduodenectomy.

Barreto SG, Windsor JA. Barreto SG, et al. Among authors: windsor ja. Lancet Oncol. 2016 Mar;17(3):e118-e124. doi: 10.1016/S1470-2045(15)00463-5. Epub 2016 Mar 2. Lancet Oncol. 2016. PMID: 26972858 Review.

8

Justifying vein resection with pancreatoduodenectomy - Author's reply.

Barreto SG, Windsor JA. Barreto SG, et al. Among authors: windsor ja. Lancet Oncol. 2016 May;17(5):e178. doi: 10.1016/S1470-2045(16)30036-5. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27301042 No abstract available.

9

Indications, techniques, and clinical outcomes of thoracic duct interventions in patients: a forgotten literature?

Wang HW, Escott AB, Phang KL, Petrov MS, Phillips AR, Windsor JA. Wang HW, et al. Among authors: windsor ja. J Surg Res. 2016 Jul;204(1):213-27. doi: 10.1016/j.jss.2016.04.050. Epub 2016 Apr 27. J Surg Res. 2016. PMID: 27451889 Review.

10

Detecting tumour response and predicting resectability after neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer.

Barreto SG, Loveday B, Windsor JA, Pandanaboyana S. Barreto SG, et al. Among authors: windsor ja. ANZ J Surg. 2019 May;89(5):481-487. doi: 10.1111/ans.14764. Epub 2018 Aug 17. ANZ J Surg. 2019. PMID: 30117669 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters